RxDoctor Payments Data

Rachel Novak, NP

Nurse Practitioner · Salem, WINPI 1699550053

Payments from drug & device makers

$1,602in general payments, 2019–2025

Across 56 payments — averaging $28.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$204
  • AstraZeneca$186
  • Johnson & Johnson$183
  • Dexcom, Inc.$174
  • Novo Nordisk$148
  • GSK$125
  • plus $582 from 13 others

What the payments were for

  • Food & beverage$1,602100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,602 in reported general payments places this provider in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$11,448
Medicare patients
81
Services billed
208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban17$13,713
JanuviaSitagliptin Phosphate12$10,064
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,253
Gabapentin51$862
Albuterol Sulfate HfaAlbuterol Sulfate35$713
Tolterodine Tartrate ErTolterodine Tartrate11$429
Omeprazole28$388
Risperidone12$383
Metoprolol Succinate37$355
Pantoprazole Sodium29$258
Atorvastatin Calcium39$243
Metformin Hcl43$227
Levothyroxine Sodium16$220
Lisinopril38$219
Bupropion XlBupropion Hcl19$214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$183$13,71317 claims
MerckJanuvia$32$10,06412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Salem

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →